Keyword

Zevalin

Description: Zevalin is a radiopharmaceutical containing ibritumomab tiuxetan, used in radioimmunotherapy for certain forms of non-Hodgkin lymphoma.
Wikidata ID: wiki/Q29006735
OpenAlex ID: keywords/zevalin
2010 · Stanley J. Goldsmith · Seminars in Nuclear Medicine · 196
2002 · Antonio J Grillo-López · Expert Review of Anticancer Therapy · 122
2016 · David Rizzieri · Critical Reviews in Oncology/Hematology · 113
2020 · Tiffany G. Chan, Edward O’Neill, et al. · Journal of Nuclear Medicine · 98
2013 · Elicia Maine, V.J. Thomas, et al. · Journal of Engineering and Technology Management · 89
2007 · Jan Tennvall, Manfred Fischer, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 88
2006 · Christos Emmanouilides, Thomas E. Witzig, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 85
2002 · Leo I Gordon, Thomas E Witzig, et al. · Seminars in Oncology · 71
2011 · Murthy R Chamarthy, Scott C Williams, et al. · PubMed Central · 59
2003 · Paul Chinn, Gary Braslawsky, et al. · Cancer Immunology Immunotherapy · 59
2001 · C. Krasner, R.M. Joyce · Current Pharmaceutical Biotechnology · 58
2019 · Christos Sachpekidis, David B. Jackson, et al. · Pharmaceuticals · 48
2007 · Christos Emmanouilides, Thomas E. Witzig, et al. · Cancer Biotherapy and Radiopharmaceuticals · 47
2011 · M. Sans Merce, N. Ruiz, et al. · Radiation Protection Dosimetry · 46
Works count: 384
Citation count: 4,357
Year
Topic
Type